Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

Summary

The objective of this study to evaluate the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of BL-M11D1 in patients with relapsed/refractory acute myeloid leukemia.

Timeline

Start

2024-12-19

Primary completion

2026-09-16

Completion

2026-09-16

Outcome

Outcome not reported

Stopped (Business): “Sponsor prioritization of other development portfolio”

Drugs

Indications